Duobrii .1 mg/g
halobetasol propionate and tazarotene · LOTION · Bausch Health US, LLC
Duobrii is a lotion containing halobetasol propionate and tazarotene at .1 mg/g, taken topical. Manufactured by Bausch Health US, LLC.
Key Facts
- Brand Name
- Duobrii
- Generic Name
- halobetasol propionate and tazarotene
- NDC Code (Product)
0187-0653- Manufacturer
- Bausch Health US, LLC
- Strength
- .1 mg/g
- Dosage Form
- LOTION
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA209354
- Drug Class
- Retinoid [EPC]
- Marketing Start
- 04/25/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Duobrii used for?
Duobrii contains halobetasol propionate and tazarotene. It is a lotion taken topical. Consult your doctor for specific uses.
Is Duobrii a controlled substance?
Duobrii is not classified as a controlled substance by the DEA.
What is the generic name for Duobrii?
The generic name for Duobrii is halobetasol propionate and tazarotene. There are no other listed brand versions of halobetasol propionate and tazarotene.
What is the NDC code for Duobrii .1 mg/g?
The NDC (National Drug Code) for Duobrii .1 mg/g is 0187-0653, listed by Bausch Health US, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)